Financial Instruments and Fair Value Disclosures - Assets Measured at Fair Value on Nonrecurring and Recurring Basis (Detail) - USD ($) $ in Thousands	4 Months Ended	8 Months Ended	12 Months Ended
	Apr. 23, 2021	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Impairment of assets	$ 197,027	$ 132,449	$ 0		$ 842,016
Nonrecurring Fair Value Measurements [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Impaired assets		77,900		$ 77,900	1,000
Impairment of assets	$ 197,027				842,016
Nonrecurring Fair Value Measurements [Member] | Level 3 [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Impaired assets		77,900		77,900	$ 1,000
Impairment of assets		132,449
Recurring Fair Value Measurements [Member] | Director [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Liability-classified Director restricted stock units		(528)	(818)	$ (528)
Total Losses		(528)	$ (230)
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]			Costs and Expenses	Costs and Expenses
Recurring Fair Value Measurements [Member] | Level 1 [Member] | Director [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Liability-classified Director restricted stock units		$ (528)	$ (818)	$ (528)